Results 251 to 260 of about 259,973 (348)

Elucidating biomarkers of carcinogenesis in ulcerative colitis: insight from Mendelian randomization and transcriptomics. [PDF]

Discov Oncol
Xiao X, Wu X, Liu T, Cai Y.
europepmc   +1 more source

Healthcare resource utilization and cost in pediatric celiac disease: A case‐control study using German insurance data

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Celiac disease (CeD) is a life‐long systemic immune‐mediated disorder. Data on burden and cost of CeD in children are scarce. We assessed healthcare resource utilization (HCRU) and cost of healthcare services of newly diagnosed children in Germany.
Sibylle Koletzko, Svitlana Schnaidt, Leonarda Serdani‐Neuhaus, Juliane Sünwoldt, Christina Dünweber, Bernd Bokemeyer   +5 more
wiley   +1 more source

Risk factors and long-term prognosis for colorectal strictures in ulcerative colitis. [PDF]

World J Gastroenterol
Shao YP, Han TT, Lv H, Yang ST, Zhu QL, Li J, Li JN.   +6 more
europepmc   +1 more source

Advancements in understanding the relationship between <i>Akkermansia muciniphila</i> and the development of ulcerative colitis. [PDF]

Front Pediatr
Xu N, Xiao X, Ma Y, Jing J, Jiang S, Luo K, Li Y, Duan M.   +7 more
europepmc   +1 more source

Cow's milk protein allergy with protein‐losing enteropathy under the scope

JPGN Reports, EarlyView.
ABSTRACT Objectives Cow's milk protein allergy (CMPA) is very frequent in infants. Presentation is variable, and symptoms fluctuate in intensity. Diagnosis can be challenging as it is mostly clinical. In severe cases, patients can present with anasarca secondary to protein‐losing enteropathy (PLE).
Morgane Thorens‐Borgeat, Géraldine Blanchard‐Rohner, Salim Ramadan, Jean‐Christophe Caubet, Laetitia‐Marie Petit, Valerie McLin, Anne‐Laure Rougemont   +6 more
wiley   +1 more source

Mendelian randomization study: Metabolites as mediators of inflammatory factors in ulcerative colitis. [PDF]

Medicine (Baltimore)
Cai M, Liu Y, Tao H, Tang L, Zhao L, Lan W, Liu X, Sheng Z, Peng Y, Sun W, Wu X, Shu Y.   +11 more
europepmc   +1 more source

Impact of biologic induction dose and concomitant drugs on anti‐drug antibody formation in a pediatric IBD cohort with high Hispanic representation

JPGN Reports, EarlyView.
Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant, Jenilee Pohle, Robert Tran, Roy Nattiv   +3 more
wiley   +1 more source

Correction to "Enteropathic SAPHO Syndrome in Ulcerative Colitis Responsive to Bisphosphonates". [PDF]

Case Rep Rheumatol
europepmc   +1 more source

Efficacy and Safety of Ustekinumab in Treatment of Ulcerative Colitis: A Systematic Review. [PDF]

Cureus
Agarwal Y, Bhatt NK, Harikrishnan S, Neelakantan Ramaswamy S, Chand S, Bendagiri Matam M, Mohammed L.   +6 more
europepmc   +1 more source